FRAND SEP licensing is often discussed as if every standard-essential patent (SEP) should carry one consistent royalty rate. In practice, licensing agreements can produce substantially different rates and cash payments without those differences automatically indicating a breach of fair, reasonable and non-discriminatory (FRAND) obligations. The reason is that an agreement reflects more than a headline price for patents: it can also account for cross-licenses, business models, portfolio characteristics and the commercial terms negotiated between the parties.
For industrial and technology decision-makers assessing connected products, the distinction between a stated rate and the net amount paid is important. Understanding how licensing arrangements work can help make royalty comparisons more meaningful and clarify why companies with sizeable SEP portfolios may report modest licensing income while specialist licensors generate more cash revenue.
FRAND SEP licensing: headline rates versus net payments
A licensing rate quoted in an offer does not necessarily show what a licensee ultimately pays. A manufacturer may grant the licensor rights to use its own patents in return, reducing or eliminating a cash payment. Agreements may also include caps, lump-sum payments, or other terms that affect the effective rate across the covered products and period.
As a result, comparisons based only on headline rates can be misleading. The relevant figures may differ depending on whether the analysis counts gross amounts requested, cash royalties actually paid, or the value assigned to rights exchanged through a cross-license. These measures answer different questions and should not be treated as interchangeable.
Factors that can contribute to variation include:
- Cross-licensing: A manufacturer with its own patent portfolio can exchange rights and reduce royalty out-payments.
- Portfolio differences: The size, strength and relevance of each party’s patents can influence negotiations.
- Contract structure: Caps, payment timing and the products or sales covered can change the effective rate.
- Disputes and enforcement: Litigation, delayed payments or differences in patent protection across jurisdictions may affect realized revenue.
- Sales reporting: Differences in reported unit volumes or prices can affect royalty calculations.
Business models shape licensing outcomes
Companies that both develop technology and manufacture devices often have two roles: they may license patents to other firms and need licenses to implement technologies owned by others. Cross-licensing can be commercially valuable because it gives each party access to technology while reducing the need for cash payments. For a device maker with significant sales, limiting royalties paid across its products may be a stronger commercial priority than maximizing the income it receives as a licensor.
A company focused primarily on licensing, rather than manufacturing devices, has a different set of incentives. It may have less need to exchange patent rights for freedom to operate in a downstream product business, so a greater share of its licensing arrangements may generate cash. This difference in business model can help explain why two patent owners with substantial portfolios do not necessarily earn similar net revenues.
The same licensor may also negotiate different effective terms with different counterparties. A licensee’s patent holdings, product sales and position in cross-licensing discussions can all vary. Consequently, a rate agreed with one manufacturer may not provide a straightforward benchmark for another.
Patent pools are not always direct benchmarks
Patent pools and other joint licensing programs can simplify access to patents covering a standard. Their terms may differ from those negotiated bilaterally, however, because the participants, licensing scope and commercial incentives are different. Pools dominated by companies that also implement the standard may reflect the interests of those downstream businesses, including a preference for limiting royalty costs.
That makes pool rates useful context, but not necessarily a like-for-like comparison for a bilateral agreement. Before relying on a pool as a benchmark, decision-makers should consider which patents and products it covers, who participates, and whether the agreement addresses comparable rights and obligations.
Why aggregate royalty estimates can diverge
Claims about the total royalty burden for a standard can vary depending on how the calculation treats cross-licenses. One approach adds the notional value of patent rights exchanged to cash royalties. Another focuses on cash payments and argues that a royalty-free cross-license does not increase a manufacturer’s marginal production cost in the same way as a running cash royalty.
The choice matters. A total based on licensors’ requested rates can differ considerably from one based on money actually paid after negotiations and cross-licensing. Any estimate should therefore state its method, explain how it handles non-cash exchanges, and avoid presenting a theoretical stack as though it were necessarily the amount paid by manufacturers.
Top-down approaches, which set an aggregate royalty level and allocate it among patent owners, involve related questions. The selected cap and allocation method can influence the result, while public commitments or court decisions may apply to particular parties and circumstances. A cap used in one context should not automatically be assumed to bind every SEP owner or define every FRAND license.
What engineers and decision-makers should examine
When reviewing a proposed license or comparing agreements, separate the underlying terms rather than relying on a single percentage. Consider whether the rate is gross or net, whether a cross-license is included, which products and standards are covered, and how caps or lump sums affect the effective payment. Also assess the basis for any comparison: a pool, bilateral license or court determination may involve different circumstances.
Market outcomes provide another part of the discussion. The source analysis points to industry entry and changes in handset market shares as evidence that companies with limited SEP portfolios have been able to enter and compete. That observation is relevant to arguments that licensing asymmetries necessarily prevent market participation, but it does not by itself determine whether an individual rate or agreement satisfies FRAND requirements.
Conclusion: assess the agreement, not just the rate
Differences in FRAND SEP licensing rates and net payments can arise from legitimate commercial factors, especially cross-licensing and the contrasting incentives of manufacturers and specialist licensors. For practical analysis, distinguish cash royalties from exchanged rights, account for contract structure, and compare agreements only when their scope and circumstances are genuinely similar. A headline rate alone is rarely enough to explain the economic result or assess the terms of a particular license.